Themes銅礦ETF COPA 深 滬
已收盤 02-06 16:00:00 美东时间
49.06
+1.900
+4.03%
華盛通- 最 高49.06
- 今 開48.89
- 成交量 4870股
- 最 低 48.48
- 昨 收 47.1596
- 總市值 1324.62万
- 52周最高 57.75
- 市盈率 靜 --
- 換手率 1.80%
- 52周最低 16.6727
- 委 比 50.00%
- 總股本 27.00万
- 歷史最高 57.75
- 量 比 0.20
- 振 幅 1.23%
- 歷史最低 16.6727
- 每 手 1
- 風險率 8.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Copart Enters Into Senior Revolving Credit Agreement
BRIEF-Copart Enters Into Senior Revolving Credit Agreement Jan 26 (Reuters) - Copart Inc CPRT.O : COPART INC - ENTERS INTO SENIOR REVOLVING CREDIT AGREEMENT - SEC FILING COPART INC - SECURES $1,250 MILLION REVOLVING CREDIT FACILITY - SEC FILING Source text: [ID:n0001193125-26-022730] Further company
01-27 06:44
Is Freeport-McMoRan's US-Based Footprint An Advantage? Analyst Upgrades Stock Amid Copper Import Tariff Risk
JP Morgan upgraded FCX to Overweight with price target of $52 from $48, citing sustained premium pricing and supply constraints, and potential protective measures for US copper imports.
2025-03-21 22:01
Freeport-McMoRan Misses Q4 Revenue Estimates, Shares Slide As Copper Sales And Revenue Decline
FCX stock down after Q4 results: revenue misses, copper sales slightly above estimate, adjusted EPS beats consensus, company expects strong future with large-scale assets, growth opportunities, and balanced copper market.
2025-01-24 00:47
BRIEF-FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)
Jan 22 (Reuters) - FDA: FDA ADDS BOXED WARNING ABOUT ANAPHYLAXIS WITH MULTIPLE SCLEROSIS MEDICINE GLATIRAMER ACETATE (COPAXONE, GLATOPA) (((( Reuters.Briefs@thomsonreuters.com ;));))
2025-01-23 01:58
